In this week's Pharma Pulse, Vicapsys merges with Stateline, Veritiv targets GLP-1 shipping, Section 232 tariffs widen and HRSA's 340B rebate pilot deadline arrives.
|Podcasts|April 1, 2022
Advancing Pharmacovigilance
Author(s)Nicholas Saraceno, Senior Editor, Julian Upton
A look into the current state of the market, along with developments in the space
Advertisement
Glenn Carroll, safety leader and principal at Deloitte Consulting, a firm that has collaborated with a Big Pharma company on an AI software-as-a-service platform, details the obstacles that drug safety providers face today, and how the competitive landscape is evolving as new entrants join the field.
The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud.
Advertisement
Related to this article
Go behind the scenes of LogiPharma USA 2026 with program director Charleen Ring and McKesson's Chris Van Norman in this Pharma Pulse special.
In this week's Pharma Pulse, DHL breaks ground on a new cold chain hub at Singapore's Changi Airport, a new report finds pharma's commercial model in the middle of a fundamental reset, and the FDA grants accelerated approval to sevabertinib.
In this week's Pharma Pulse, nine more drugmakers join the MFN program, GoodRx adds a family plan, IPC formalizes its USave partnership, and CSafe expands its thermal cover offerings.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Supply Chain Signal: How Policy Pressures Are Converging on Pharma
2
Why Temperature Control Is Now Pharma’s Make-or-Break Variable
3
Pharma Pulse: Vicapsys-Stateline Merger and Veritiv's TempSafe RxShield
4
Copeland Closes Dickson Deal to Expand Cold Chain Monitoring
5